Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lantibio, TRB Chemedica, Alcon Laboratories Inc. deal

Lantibio and TRB granted Alcon exclusive U.S. rights to commercialize

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE